Antidepressive AgentsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorElectroconvulsive TherapyDepressive DisorderSubstance-Related DisordersSubstance Abuse Treatment CentersAntidepressive Agents, TricyclicResidential TreatmentAntidepressive Agents, Second-GenerationFluoxetineEating DisordersSerotonin Uptake InhibitorsDrug ResistanceCitalopramTreatment OutcomeImipramineDesipramineAntipsychotic AgentsSertralineCognitive TherapyCyclohexanolsDepressionNortriptylineParoxetineAmitriptylineMianserinPsychiatric Status Rating ScalesPhenelzineTranylcypromineAdrenergic Uptake InhibitorsAnxiety DisordersBipolar DisorderMood DisordersSwimmingMonoamine Oxidase InhibitorsDiagnostic and Statistical Manual of Mental DisordersSerotonin Plasma Membrane Transport ProteinsSuicideBrain-Derived Neurotrophic FactorClomipramineBupropionBrainAnhedoniaStress, PsychologicalPsychotherapyFluvoxamineDysthymic DisorderSerotoninPersonality InventoryBehavior, AnimalHelplessness, LearnedComorbidityMental DisordersHippocampusReceptor, Serotonin, 5-HT1ASeverity of Illness IndexElectroshockTime FactorsAnalysis of VarianceZimeldineAnxietyDouble-Blind MethodAffectDrug Therapy, CombinationRats, Sprague-DawleyBiogenic MonoaminesPharmacogeneticsPsychotropic DrugsDothiepinReceptors, Serotonin, 5-HT1TrazodoneReceptors, SerotoninDrug Administration ScheduleHypothalamo-Hypophyseal SystemMaprotilineGyrus CinguliDose-Response Relationship, DrugRecurrenceBuspironeFollow-Up StudiesAnti-Anxiety AgentsTupaiaSuicide, AttemptedRisk FactorsPrefrontal CortexPituitary-Adrenal SystemCorticosteroneInterview, PsychologicalMotor ActivityRandomized Controlled Trials as TopicAmygdalaDisease Models, AnimalFrontal LobeEmotionsExploratory BehaviorMedication AdherenceProspective StudiesBenzodiazepinesQuestionnaires